Preclinical HbA1c level studies of Brihat Khadir Batika and Chandraprabha Batika after chronic administration to male Sprague-Dawley rats

• Published in: International journal of basic and clinical pharmacology Vol. 7; no. 11; p. 2151
• Main Authors: Hafsa Asha, Umma, Saha, Nilay, Sikder, Md. Mamun, Akter, Khadija, Sony, Tahmina Akter, Sinha, Md. Hasif, Rahman, Md Mahabur, Choudhuri, M. S. K.
• Format: Journal Article
• Language: English
• Published: 01.11.2018
• ISSN: 2319-2003; 2279-0780
• DOI: 10.18203/2319-2003.ijbcp20184319

Background: Brihat Khadir Batika (BKD) and Chandraprabha Batika (CPB) are Ayurvedic preparations used as traditional medicines for different clinical indications in the rural population. BKD is used in diseases of throat and CPB is used in glandular enlargement. In this study we evaluate the influence of these preparations on HbA1c (%) level.Methods: To find out the average plasma glucose concentration over prolonged period of time, Ayurvedic medicinal preparations BKD and CPB were administered chronically to the male Sprague-Dawley rats at a dose of 400 mg/kg. After 28 days of chronic administration of BKD and CPB the following changes were noted. In this experiment Glycated Hemoglobin A1C level was determined.Results: The results of the study of in vitro quantitative determination of rat Glycated hemoglobin A1c concentrations in serum studies are thus: BKD caused a statistically insignificant (p=0.066) increase in the HbA1c level of the male rat (16.87% increase). CPB demonstrated a statistically insignificant (p=0.079) (17.47%) increase in the HbA1C level of the blood of the male rat.Conclusions: Both preparation BKD and CPB found in increasing HbA1c level of the blood of the male rat.